Monash IVF Group Limited (ASX:MVF)
0.7950
-0.0050 (-0.63%)
Aug 1, 2025, 4:10 PM AEST
Accolade Market Cap
Monash IVF Group has a market cap or net worth of 309.76 million as of August 1, 2025. Its market cap has decreased by -37.65% in one year.
Market Cap
309.76M
Enterprise Value
466.32M
Revenue
269.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.80
Market Cap Chart
Since June 26, 2014, Monash IVF Group's market cap has decreased from 534.53M to 309.76M, a decrease of -42.05%. That is a compound annual growth rate of -4.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 311.71M | -37.01% |
Dec 31, 2024 | 494.84M | -2.31% |
Dec 29, 2023 | 506.53M | 36.13% |
Dec 30, 2022 | 372.10M | -9.48% |
Dec 31, 2021 | 411.06M | 34.39% |
Dec 31, 2020 | 305.86M | 25.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 131.27B |
Pro Medicus | 33.40B |
Cochlear | 20.72B |
Sonic Healthcare | 13.69B |
Ramsay Health Care | 8.94B |
Telix Pharmaceuticals | 7.00B |
Ansell | 4.38B |
Mesoblast | 3.13B |